Probiotic co-administration attenuates developmental cafeteria diet-induced cellular stress and NLRP3 inflammasome

Aysun Inan Genc1

  • 1Department of Biology, Kastamonu University, Kastamonu, Türkiye.

Insights

Early life cafeteria diet exposure alters spleen immune markers, increasing apoptosis and impairing autophagy. Probiotics partially mitigated these cafeteria diet (Cd) effects on splenic immune dysregulation.

Area of Science:

  • Immunometabolism
  • Developmental Biology
  • Nutritional Immunology

Background:

  • Early life exposure to obesogenic diets can cause lasting immunometabolic problems.
  • The impact of such dietary stress on spleen apoptosis, autophagy, and inflammasome signaling during development is not well understood.

Purpose of the Study:

  • To investigate if probiotic supplementation can modify molecular changes in spleen tissue induced by a cafeteria diet (Cd) during the post-weaning period.
  • To assess the effects of Cd and probiotics on splenic apoptosis, autophagy, and inflammasome signaling.

Main Methods:

  • Male Wistar rats (postnatal day 21) were fed a control diet, cafeteria diet (Cd), probiotics (Prb), or Cd plus probiotics (Cd+Prb) until day 56.
  • Splenic apoptosis, autophagy, and inflammasome markers were analyzed using RT-qPCR and immunohistochemistry.

Main Results:

  • Cd exposure promoted splenic apoptosis (increased BAK, Caspase-3, BAX) and impaired autophagy (decreased ATG5, increased p62).
  • Cd increased inflammasome markers (NLRP3, IL-18) at both gene and protein levels.
  • Probiotics partially attenuated Cd-induced changes, notably reducing NLRP3 protein levels and normalizing BCL2 and IL-18 expression.

Conclusions:

  • Developmental exposure to a cafeteria diet induces splenic immune dysregulation, affecting apoptosis, autophagy, and inflammasome pathways.
  • Probiotic supplementation partially modulated these Cd-induced alterations in a context-dependent manner.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...